News Headline Summary

Bristol Myers (BMY) says study data didn't warrant a phase III study

Reaction details:

- Co. shares dropped 0.6% in reaction to this headline, moving from USD 32.58 to USD 32.39; trades USD 32.45 last.

Print 18:39, 03 Dec 2012 - US Equities - Source: Newswires